DirectorIlan Oren has served as a member of the Board since May, 2020. Ilan also served as Co-Chief Executive Officer of Dexcel Pharma, a privately-owned Israeli group of pharmaceutical companies, since November 2019. He is currently on the board of Clexio Biosciences and Roivant Sciences. Prior to serving as Co-CEO, he served as Vice President for the group and led corporate and business development activities, including formation of strategic ventures, product partnerships, product portfolio selection, product acquisitions, strategic investments, and mergers and acquisitions. Ilan holds an A.B. in Economics from Harvard College.